Rx Economic Information-Sharing Concept Getting Renewed Push
This article was originally published in The Pink Sheet Daily
Executive Summary
Payers join biopharma in seeking clarity around information-sharing provisions in FDAMA Sec. 114 – and in expanding the kind of off-label data that could be disseminated under the law.